# Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin
> **Food and Drug Administration** · Final rule. · Published 2000-07-21 · Effective 2000-07-21 · 65 FR 45282
## Document
- **Document number:** 00-18458
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 45282
- **CFR reference:** 21 CFR 524
- **Publication date:** 2000-07-21
- **Effective date:** 2000-07-21
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for topical veterinary prescription use of selamectin solution for the additional indication for control of intestinal hookworm and roundworm infections in cats.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/07/21/00-18458/ophthalmic-and-topical-dosage-form-new-animal-drugs-selamectin)
---
*AI Analytics · CC0 1.0*